Vaccination Archives - Page 3 of 14 - Infectious Disease Advisor

Hexavalent Vaccine Included in Pediatric Vaccination Program

February 13, 2020

The DTaP-IPV-Hib-HepB vaccine has safety profile consistent with licensed comparator vaccines and has been included in the federal Vaccines for Children program.

Prevention

ACIP Updates Recommendations for Tdap Vaccination

By

Infectious Disease Advisor Contributing Writer

February 11, 2020

Updated recommendations for the use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine have been developed by the Advisory Committee on Immunization Practices (ACIP).

Prevention

ACIP: 2020 Child and Adolescent Immunization Schedule Updates

By

Diana Ernst, RPh

February 10, 2020

The ACIP has released an updated version of the child and adolescent immunization schedule for ages 18 years and younger in the United States.

Vector-borne Illnesses

Intradermal Rabies Vaccine Noninferior to Intramuscular Vaccine

By

Zahra Masoud

February 6, 2020

Intradermal administration of the rabies vaccine may produce similar antibody titers at a fraction of the intramuscular administration dose.

Prevention

ACIP: 2020 Adult Immunization Schedule Updates

By

Brian Park, PharmD

February 6, 2020

The ACIP has released an updated version of the adult immunization schedule for ages 19 years and older in the United States.

Influenza

Many US Adults Misinformed About the Flu, Vaccination

January 30, 2020

Many US adults are misinformed about the influenza virus and the importance of flu vaccination.

Prevention

ACIP: Updated Recommendations for Tdap Vaccination

By

Brian Park, PharmD

January 28, 2020

ACIP has updated recommendations to allow for the use of the Tdap vaccine for the decennial tetanus and diphtheria toxoid booster.

Influenza

Enhanced Influenza Vaccines Offer Improved Antibody Response in Older Adults

By

Sweta Gupta

January 24, 2020

Compared with a standard-dose influenza vaccine, several enhanced influenza vaccines improved humoral and cell-mediated immune responses in older adults.